Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 275-282

  Singh, Ram B ^a   Shinde, Suresh N ^a   Chopra, Raj K ^b   Niaz, Mohammad A ^a   Thakur, Amar S ^a   Onouchi, Z ^c  

^a Medical Hospital and Research Centre Moradabad   (India)

^b Tishcon Corporation   (United States)

^c Childrens Research Hospital   (Japan)

Author keywords

Antioxidants; Cholesterol; Coenzyme Q10; Composition of atheroma; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM HYDROXIDE; ANTIOXIDANT; ASCORBIC ACID; CHOLESTEROL; FATTY ACID; FERRIC CHLORIDE; MALONALDEHYDE; PLACEBO; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CHEMICAL COMPOSITION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; LIPID DIET; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL; CORONARY VESSELS; RABBITS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES; UBIQUINONE; VITAMIN E;

EID: 0033956180     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00273-7     Document Type: Article

References (35)

1. Carew T., Schwenke D., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect, evidence that anti-oxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the Watanebe heritable hyperlipidemic rabbits. Proc. Natl. Acad. Sci. USA. 84:1987;7725-7729.
2. Witztum J.L. The oxidative hypothesis of atherosclerosis. Lancet. 344:1994;793-796.
3. Anderson T.J., Meridith I.T., Yeung A.C. The effect of cholesterol lowering and antioxidant therapy on endothelium dependent coronary vasomotion. New. Engl. J. Med. 332:1995;488-493.
4. Smith T.L., Kummerow F.A. Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted anovulatory chickens. Atherosclerosis. 79:1989;105-109.
5. Singh R.B., Singh N.K., Rastogi S.S., Wander G.S., Aslam M., Onouchi Z. et al. Antioxidant effects of lovastatin and vitamin e on experimental atherosclerosis in rabbits. Cardiovasc. Drug Ther. 11:1997;575-580.
6. Singh R.B., Niaz M.A., Agarwal P., Ahmad S., Beegom R., Qnouchi Z., Kummerow F.A. Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress and development of experimental atherosclerosis. Cariovasc. Drug Ther. 9:1996;763-771.
7. Stocker R.A role for reduced coenzyme Q in atherosclerosis. (Abstract). The first conference of the international coenzyme Q10 association. Boston, USA, May 21-24, 1998 Program and Abstracts, P 41-43.
8. Sugiyama S., Kitazawa M., Oxawa T., Suziki K., Izawa Y. Antioxidative effect of coenzyme Q10. Experimentia. 36:1980;1002-1006.
9. Ondarroa M., Quinn P. Proton magnetic resonance spectroscopic studies of the interaction of ubiquinone-10 with phospholipid membranes. Int. J. Biochem. 155:1986;353-357.
10. Stocker R., Bowry V.W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol, Proc. Natl. Acad. Sci. USA. 88:1991;1646-1650.
11. Serebruany V.L., Ordonez J.V., Herog W.R., Rohde M., Mortensen S.H., Folers K., Gurbel P.A. Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CDS1/CD 61) receptor expression. J. Cardiovasc. Pharmacol. 29:1997;16-22.
12. Singh R.B., Wander G.S., Rastogi A., Shukla P.K., Mittal A., Sharma J.P. et al. Randomised, double blind placebo controlled trial of coenzyme Q10 in patient with acute myocardial infarction. Cardiovas. Drug Ther. 12:1998;347-353.
13. Merati G, Pasquali P, Vergani C, Landi L. Antioxidant activity of ubiquinone-3 in human low density lipoprotein, Free Rad Res Commun 1992; 16: 11-17.
14. Mohr D., Bowry V.W., Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of coenzyme Q10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta. 1126:1992;247-254.
15. Singh R.B., Niaz M.A., Rastogi V., Rastogi S.S. Coenzyme Q in cardiovascular disease. J. Assoc. Phys. India. 46:1998;299-306.
16. Singh RB, Niaz MA, Rastogi SS, Verma SP. Coenzyme Q10 and its role in heart disease, J Clin Biochem Nutr 1999;26:109-119.
17. Niato C., Kawamura M., Yamamoto Y. Lipid peroxides as the initiating factor of atherosclerosis. Annu. NY Acad. Sci. 676:1993;27-45.
18. Lunec J., Hallovan S.P., White A.G., Dormandy T.L. Free radical oxidation (peroxidaiton) products in serum and synovial fluids in rheumatoid arthritis. J. Rheumatol. 8:1981;233-246.
19. Esterbaner H., Cheeseman K.H. Determination of aldehyde peroxidation products malonyldialdehyde an 4-hydroxynomenal. Methods Enzymol. 186:1990;407-421.
20. Vuilleurnieer J.P., Keller H.e, Gysel D., Hunziker F. Clinical chemical methods for routine assessment of the vitamin status in human. Int. J. Vit. Nutr. Res. 53:1983;265-272.
21. Alllain C.C., Poon L.S., Chan C.S., Richmand W., Fu P.C. enzymatic determination of total serum cholesterol. Clin. Chem. 20:1974;470-475.
22. Buecolo G., Devi H. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 79:1997;476-482.
23. Singh R.B., Niaz M.A., Ghosh S., Beegom R., Bishnoi I., Agarwal P., Agarwal A. Dietary intake and plasma levels of antioxidant vitamins in health and disease: a hospital based case control study. J. Nutr. Environ. Med. 5:1995;235-242.
24. Kritchevsky D., Tepper S.A., Stary J.A. Cholesterol vehicle in experimental atherosclerosis, part 16, effect of peanut oil on preestablished lesions. Atherosclerosis. 31:1978;365-370.
25. Charkravarti R.N., Mohan A.P., Komal H.S. Atherosclerosis in Macca mulatta: histopathological, morphometric and histochemical studies in aorta and coronary arteries of spontaneous and induced atherosclerosis. Exp. Mol. Pathol. 25:1976;390-401.
26. Kukreja R.S., Datta B.N., Chakravarti R.N. Catecholamine induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis. 40:1981;291-298.
27. Bansal N., Majumdar S., Chakravarti R.N. Frequency and size of atherosclerotic plaques in vasectomized diabetic monkeys. Int. J. Fert. 31:1986;298-304.
28. Kontush A., Reich A., Baum K., Spranger T., Finckh B., Kohlschutter A., Beisiegel U. Plasma Ubiquinol-10 is decreased in patients with hyperlipidemia. Atherosclerosis. 129:1997;119-126.
29. Littarru G.P., Ho L., Folkers K. Deficiency of coenzyme Q10 in human heart disease II. Int. J. Vit. Nutr. Res. 42:1972;413-417.
30. Littarru G.P., Ho L., Folkers K. Deficiency of coenzyme Q10 in human heart disease. Int. J. Vit. Nutr. Res. 42:1972;291-295.
31. Kamikawa T., Kobayashi A., Yamashita T., Hayashi H., Yamazaki N. effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am. J. Cardiol. 58:1985;247-251.
32. Kuklinski B., Weissenbacher e, Fahnrich A. Coenzyme Q10 and antioxidants in acute myocardial infarction. Mol. Aspects Med. Suppl. 15:1994;143-147.
33. Mortension S.A., Vadhanavikit S., Muratsu K., Folkers K. Coenzyme Q10 clinical benefits with biochemical correlates suggesting a scientific break through in the management of chronic failure. Int. J. Tissue React. 12:1990;167-171.
34. Frei B., Kim M.C., Ames B.N. Ubiquinol-10 is an effective lipid soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. USA. 87:1990;4879-4883.
35. Andree P, Dallner G, Ernster L. Ubiquinol: an endogenous lipid soluble antioxidant in animal tissues. In: Ozben, Free Radicals, Oxidative stress and Antioxidants. New York: Plenum press, 1998, p. 293-314.